Literature DB >> 11694337

Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens.

C Avancès1, V Georget, B Térouanne, F Orio, O Cussenot, N Mottet, P Costa, C Sultan.   

Abstract

The human immortalized prostatic cell line PNT1A has been proved to be a good model for analysis of cellular processes such as the prostatic epithelium proliferation in response to androgens and growth factors. Here we used this cell line for studying the transcriptional activity and trafficking of the androgen receptor (AR) by analyzing several actions of antiandrogens. Transient transfection experiments with PNT1A cells were performed with wild type human AR and an androgen-responsive gene reporter. We demonstrated that the transcription of reporter gene could be triggered by natural androgens (testosterone and dihydrotestosterone) in PNT1A cells as well as in the prostatic carcinoma cell line DU-145. With competitive experiments in the two cell lines, we observed no difference between the antagonistic capacity of cyproterone acetate (CPA) and hydroxyflutamide at 10(-7) M. At this concentration, bicalutamide antagonist activity was lower. In parallel, we compared the subcellular localization of the modified green fluorescent protein (EGFP)-AR in COS-7, PNT1A and DU-145 cell lines under fluorescence microscopy: we found different distributions between nucleus and cytoplasm, depending on the cell line and the culture medium. Androgen induced cluster formation within the nucleus of the PNT1A and DU-145 cells. However, the cytonuclear trafficking of androgen bound EGFP-AR in the same living cell and nuclear foci were easier to examine in the PNT1A cells. The antiandrogen capacity of bicalutamide was manifested by a slower androgen-dependent nuclear transfer of EGFP-AR and a homogeneous nuclear localization. A delayed advent of nuclear clusters was observed in presence of CPA. We conclude that the PNT1A cell line is a better model than the DU-145 cell line to analyze the trafficking of AR and the association of AR on the nuclear matrix, as well as to observe the action of antiandrogens on these critical steps in prostate cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694337     DOI: 10.1016/s0303-7207(01)00669-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Ligand-specific dynamics of the androgen receptor at its response element in living cells.

Authors:  Tove I Klokk; Piotr Kurys; Cem Elbi; Akhilesh K Nagaich; Anindya Hendarwanto; Thomas Slagsvold; Ching-Yi Chang; Gordon L Hager; Fahri Saatcioglu
Journal:  Mol Cell Biol       Date:  2006-12-22       Impact factor: 4.272

Review 2.  Androgen receptor signaling and mutations in prostate cancer.

Authors:  Shahriar Koochekpour
Journal:  Asian J Androl       Date:  2010-08-16       Impact factor: 3.285

3.  Leucine zipper, down regulated in cancer-1 gene expression in prostate cancer.

Authors:  Michele Salemi; Nunziata Barone; Sandro La Vignera; Rosita A Condorelli; Domenico Recupero; Antonio Galia; Filippo Fraggetta; Anna Maria Aiello; Pietro Pepe; Roberto Castiglione; Enzo Vicari; Aldo E Calogero
Journal:  Oncol Lett       Date:  2016-08-10       Impact factor: 2.967

4.  A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line.

Authors:  Kamila Domińska; Tomasz Ochędalski; Karolina Kowalska; Zuzanna E Matysiak-Burzyńska; Elżbieta Płuciennik; Agnieszka W Piastowska-Ciesielska
Journal:  J Physiol Biochem       Date:  2016-04-27       Impact factor: 4.158

5.  The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function.

Authors:  Barbara Comuzzi; Leonidas Lambrinidis; Hermann Rogatsch; Sonia Godoy-Tundidor; Nikola Knezevic; Ivan Krhen; Zvonimir Marekovic; Georg Bartsch; Helmut Klocker; Alfred Hobisch; Zoran Culig
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

6.  Integrative proteomic and phosphoproteomic profiling of prostate cell lines.

Authors:  Maria Katsogiannou; Jean-Baptiste Boyer; Alberto Valdeolivas; Elisabeth Remy; Laurence Calzone; Stéphane Audebert; Palma Rocchi; Luc Camoin; Anaïs Baudot
Journal:  PLoS One       Date:  2019-11-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.